Steric disruption of EGFR oligomerization overcomes therapy resistance in non-small cell lung cancer
{{output}}
Acquired drug resistance mutations in epidermal growth factor receptor (EGFR) present a substantial clinical challenge in treating non-small cell lung cancer (NSCLC). While EGFR oligomerization plays a pivotal role in modulating receptor signaling, its relatio... ...
